Epigral Limited''s reply to clarification sought by the Stock Exchange with reference to Movement in Volume.

22.07.2026 BSE Limited Floor- 25, P J Tower, Dalal Street, Mumbai 400 001 SCRIP CODE: 543332 Dear Sirs, Sub.: Clarification sought from Epigral Limited – Volume Movement Ref.: Letter No.: L/SURV/ONL/PV/SG/ 2026-2027 / 259 dated 22.07.2026 This has reference to the letter received from BSE Limited regarding increase in Volume of Epigral Limited (‘the Company’) across Exchanges. In this regard, we wish to inform you that the Company has made all the necessary disclosures having bearing on the operation/performance of the Company, which include all price sensitive information and information concerning the Company, pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and has not withheld any material information / event that in our opinion would have bearing on the price behaviour of the scrip and concerning the Company. The Company shall continue to make applicable disclosures, within the stipulated time as per the said regulation. The movement in the volume / share price of the Company is due to market conditions and market driven and the Company is not connected with any such movement in volume / price. We request you to take note of the above and place it for information of members. Thanking you, Yours faithfully, For Epigral Limited Gaurang Trivedi Company Secretary & Compliance Officer M. No. – A22307